🎁 Black Friday: up to 50% off of annual plans
Apex Biotechnology Corp. (TPE:1733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.00
-0.70 (-2.44%)
Nov 20, 2026, 1:30 PM CST

Apex Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
185.61162.89128115.78181.79202.22
Depreciation & Amortization
56.8959.8363.4174.1992.7194.32
Other Amortization
1.091.091.41.521.391.35
Asset Writedown & Restructuring Costs
---17.786-
Loss (Gain) From Sale of Investments
5.03-14.98-4.233.9629.48-31.7
Stock-Based Compensation
-----1.59
Provision & Write-off of Bad Debts
-13.0514.320.051.82--3.5
Other Operating Activities
5.75-9.32-11.2410.85-45.7433.62
Change in Accounts Receivable
34.8-88.39-58.6188.87-1.38-160.77
Change in Inventory
-147.6990.5267.61-17.96-116.67-136.05
Change in Accounts Payable
44.55-4.3467.96-96.22-59.5199.31
Change in Unearned Revenue
1.98-51.0551.68-22.45-64.0250.45
Change in Other Net Operating Assets
11.33-0.4722.64-47.742.5629.02
Operating Cash Flow
186.29160.12328.67230.3926.62179.87
Operating Cash Flow Growth
-16.39%-51.28%42.66%765.61%-85.20%-35.90%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-15.26-15.26-28.24-21.91-36.58-26.59
Sale (Purchase) of Intangibles
-2.44-4-1.39-3.07-4.07-3.6
Investment in Securities
-9.8---0.7-2
Other Investing Activities
1.843.92-5.962.48-0.01-2.83
Investing Cash Flow
-23.3-5.54-35.6-22.5-41.37-35.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-18.2729.45281.16964.611,690
Total Debt Issued
14.418.2729.45281.16964.611,690
Short-Term Debt Repaid
--18.27-59.45-301.16-1,065-1,540
Long-Term Debt Repaid
--8.72-8.7-8.2-7.68-404.2
Lease Payments
-9.41-8.72-8.7-8.2-7.68-6.49
Total Debt Repaid
-23.81-26.98-68.15-309.35-1,072-1,944
Net Debt Issued (Repaid)
-9.41-8.72-38.7-28.2-107.68-254.2
Issuance of Common Stock
-----12.25
Common Dividends Paid
-129.94-119.94-109.95-139.93-129.94-109.32
Other Financing Activities
---0.03-0.020.01-0.01
Financing Cash Flow
-139.35-128.66-148.67-168.14-237.6-351.27

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
10.288.496.2410.5928.72-25.19
Net Cash Flow
33.9334.41150.6450.34-223.63-231.61

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
171.03144.86300.43208.48-9.97153.28
Free Cash Flow Growth
-20.57%-51.78%44.10%---34.87%
Free Cash Flow Margin
9.21%7.45%16.22%12.44%-0.44%7.19%
Free Cash Flow Per Share
1.711.442.992.08-0.101.45
Levered Free Cash Flow
110.0398.15254.23164.39-78.1855.06
Unlevered Free Cash Flow
112.11100.27256.51167.14-74.8162.89
Free Cash Flow After Leases
161.62136.14291.73200.28-17.65146.79

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.393.393.644.395.44.7
Cash Income Tax Paid
21.7721.7748.4318.924.049.19
Change in Working Capital
-55.02-53.73151.294.5-239.01-118.04